IN2014MN02418A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02418A IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
- Authority
- IN
- India
- Prior art keywords
- methods
- breast cancer
- subject
- gene expression
- evaluating
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 6
- 206010006187 Breast cancer Diseases 0.000 abstract 5
- 208000026310 Breast neoplasm Diseases 0.000 abstract 5
- 230000014509 gene expression Effects 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000002493 microarray Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000003753 real-time PCR Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650209P | 2012-05-22 | 2012-05-22 | |
| US201361753673P | 2013-01-17 | 2013-01-17 | |
| PCT/US2013/042157 WO2013177245A2 (fr) | 2012-05-22 | 2013-05-22 | Gènes nano-46 et procédés de prédiction de l'évolution du cancer du sein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02418A true IN2014MN02418A (fr) | 2015-08-14 |
Family
ID=49624503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2418MUN2014 IN2014MN02418A (fr) | 2012-05-22 | 2013-05-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130337444A1 (fr) |
| EP (1) | EP2852689B1 (fr) |
| JP (1) | JP6325530B2 (fr) |
| CN (2) | CN104704128A (fr) |
| AU (1) | AU2013266419B2 (fr) |
| BR (1) | BR112014029300A2 (fr) |
| CA (1) | CA2874492C (fr) |
| ES (1) | ES2763931T3 (fr) |
| IL (1) | IL235795B (fr) |
| IN (1) | IN2014MN02418A (fr) |
| MX (1) | MX369628B (fr) |
| WO (1) | WO2013177245A2 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009262894B2 (en) | 2008-05-30 | 2014-01-30 | British Columbia Cancer Agency Branch | Gene expression profiles to predict breast cancer outcomes |
| US9066963B2 (en) | 2011-03-15 | 2015-06-30 | The University Of North Carolina At Chapel Hill | Methods of treating breast cancer with anthracycline therapy |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| EP2785873A4 (fr) | 2011-11-30 | 2015-11-11 | Univ North Carolina | Procédés de traitement du cancer du sein avec une thérapie au taxane |
| US9593365B2 (en) | 2012-10-17 | 2017-03-14 | Spatial Transcriptions Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| WO2014186349A1 (fr) * | 2013-05-13 | 2014-11-20 | Nanostring Technologies, Inc. | Procédés de prédiction du risque de récurrence de cancer du sein de stade précoce à ganglions positifs |
| DK3013983T3 (da) | 2013-06-25 | 2023-03-06 | Prognosys Biosciences Inc | Spatialt kodede biologiske assays ved brug af en mikrofluidisk anordning |
| JP2016537010A (ja) * | 2013-09-09 | 2016-12-01 | ブリティッシュ コロンビア キャンサー エージェンシー ブランチ | 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット |
| US20160194701A1 (en) | 2014-11-21 | 2016-07-07 | Nanostring Technologies, Inc. | Enzyme- and amplification-free sequencing |
| US10246700B2 (en) * | 2014-11-24 | 2019-04-02 | Nanostring Technologies, Inc. | Methods and apparatuses for gene purification and imaging |
| WO2016091880A1 (fr) * | 2014-12-09 | 2016-06-16 | King's College London | Traitement du cancer du sein avec une thérapie au taxane |
| CN120425026A (zh) | 2015-04-10 | 2025-08-05 | 十程基因技术瑞典公司 | 生物样本的空间区别、多重核酸分析 |
| CN107850599B (zh) * | 2015-07-23 | 2021-02-09 | 新加坡国立大学 | Wbp2与her2作为共预后因子对患者分层以进行治疗 |
| US20170327876A1 (en) | 2016-05-16 | 2017-11-16 | Nanostring Technologies, Inc. | Methods for detecting target nucleic acids in a sample |
| WO2017222453A1 (fr) | 2016-06-21 | 2017-12-28 | Hauling Thomas | Séquençage d'acide nucléique |
| WO2018074865A2 (fr) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | Composition et procédé pour la prédiction de pronostic du cancer du sein |
| KR102476709B1 (ko) | 2016-11-21 | 2022-12-09 | 나노스트링 테크놀로지스, 인크. | 화학적 조성물 및 이것을 사용하는 방법 |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| US11978535B2 (en) * | 2017-02-01 | 2024-05-07 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
| CA3078158A1 (fr) | 2017-10-06 | 2019-04-11 | Cartana Ab | Ligature a matrice d'arn |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| JP7525402B2 (ja) | 2018-05-14 | 2024-07-30 | ナノストリング テクノロジーズ，インコーポレイティド | 化学的組成物とそれを利用する方法 |
| CN113302313A (zh) * | 2018-11-05 | 2021-08-24 | 拜恩科技诊断有限责任公司 | 乳腺癌的预测方法 |
| SG11202111878RA (en) | 2019-05-31 | 2021-11-29 | 10X Genomics Inc | Method of detecting target nucleic acid molecules |
| JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
| GB201919032D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
| EP4484571A3 (fr) | 2020-02-21 | 2025-03-19 | 10X Genomics, Inc. | Procédés et compositions pour un dosage spatial in situ intégré |
| US12209273B2 (en) | 2020-06-12 | 2025-01-28 | 10X Genomics, Inc. | Nucleic acid assays using click chemistry bioconjugation |
| EP3945136A1 (fr) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | Procédé in vitro pour le pronostic de patients souffrant d'un cancer du sein her2-positif |
| US12297499B2 (en) | 2020-08-17 | 2025-05-13 | 10X Genomics, Inc. | Multicomponent nucleic acid probes for sample analysis |
| US12509717B2 (en) | 2020-12-11 | 2025-12-30 | 10X Genomics, Inc. | Methods and compositions for multimodal in situ analysis |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| CA3248919A1 (fr) * | 2021-12-20 | 2023-06-29 | Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomèdiques August Pi I Sunyer | Développement et validation d'un procédé in vitro pour le pronostic de patients souffrant d'un cancer du sein her2-positif |
| CN117965734B (zh) * | 2024-02-02 | 2024-09-24 | 奥明星程(杭州)生物科技有限公司 | 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| DK0604552T3 (da) | 1991-09-18 | 1997-08-04 | Affymax Tech Nv | Fremgangsmåde til syntese af forskellige samlinger af oligomerer |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5677195A (en) | 1991-11-22 | 1997-10-14 | Affymax Technologies N.V. | Combinatorial strategies for polymer synthesis |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0880598A4 (fr) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite |
| AU1287799A (en) | 1997-10-31 | 1999-05-24 | Affymetrix, Inc. | Expression profiles in adult and fetal organs |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
| EP3170906B1 (fr) * | 2003-06-24 | 2018-08-22 | Genomic Health, Inc. | Prédiction de probabilité de récurrence de cancer |
| US20050071087A1 (en) * | 2003-09-29 | 2005-03-31 | Anderson Glenda G. | Systems and methods for detecting biological features |
| CA2574447A1 (fr) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Genes domestiques et methodes d'identification desdits genes |
| CN101061480A (zh) * | 2004-09-22 | 2007-10-24 | 三路影像公司 | 用来分析和优化用于癌症诊断的标记候选物的方法和计算机程序产品 |
| CA2630974A1 (fr) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methodes et compositions dans lesquelles sont utilises des genes intrinseques |
| ATE525482T1 (de) | 2005-12-23 | 2011-10-15 | Nanostring Technologies Inc | Nanoreporter und verfahren zu deren herstellung und verwendung |
| JP5700911B2 (ja) | 2005-12-23 | 2015-04-15 | ナノストリング テクノロジーズ，インコーポレーテッド | 配向され、固定化された巨大分子を含む組成物とその製造法 |
| AU2008237018B2 (en) | 2007-04-10 | 2014-04-03 | Bruker Spatial Biology, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| WO2008150512A2 (fr) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Procédés pour identifier une plus grande probabilité de récidive du cancer du sein |
| JP2010538609A (ja) * | 2007-09-06 | 2010-12-16 | バイオセラノスティクス，インコーポレイティド | 腫瘍グレード分類と癌の予後診断 |
| AU2009262894B2 (en) * | 2008-05-30 | 2014-01-30 | British Columbia Cancer Agency Branch | Gene expression profiles to predict breast cancer outcomes |
| ES2684317T3 (es) | 2008-08-14 | 2018-10-02 | Nanostring Technologies, Inc | Nanoinformadores estables |
| WO2011120984A1 (fr) * | 2010-03-31 | 2011-10-06 | Sividon Diagnostics Gmbh | Procédé pour prédire la récurrence du cancer du sein sous traitement endocrinien |
-
2013
- 2013-05-22 CA CA2874492A patent/CA2874492C/fr active Active
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/fr active Active
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/fr not_active Ceased
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104704128A (zh) | 2015-06-10 |
| JP2015518724A (ja) | 2015-07-06 |
| CN111500718A (zh) | 2020-08-07 |
| WO2013177245A2 (fr) | 2013-11-28 |
| US20200332368A1 (en) | 2020-10-22 |
| IL235795A0 (en) | 2015-01-29 |
| JP6325530B2 (ja) | 2018-05-16 |
| IL235795B (en) | 2020-02-27 |
| BR112014029300A2 (pt) | 2017-07-25 |
| AU2013266419A1 (en) | 2014-12-11 |
| US20230272476A1 (en) | 2023-08-31 |
| MX369628B (es) | 2019-11-14 |
| EP2852689B1 (fr) | 2019-12-11 |
| AU2013266419B2 (en) | 2018-09-27 |
| WO2013177245A3 (fr) | 2015-01-29 |
| EP2852689A4 (fr) | 2016-05-11 |
| ES2763931T3 (es) | 2020-06-01 |
| CA2874492A1 (fr) | 2013-11-28 |
| CA2874492C (fr) | 2021-10-19 |
| MX2014014275A (es) | 2015-07-06 |
| US20130337444A1 (en) | 2013-12-19 |
| EP2852689A2 (fr) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX369628B (es) | Genes nano46 y metodos para predecir el resultado del cancer de mama. | |
| CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
| EA201390762A1 (ru) | Новые биомаркеры для предсказания исхода противораковой иммунотерапии | |
| MX2019007814A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
| EP2663656A1 (fr) | Variants génétiques comme marqueurs à utiliser dans l'évaluation du risque, le diagnostic, le pronostic et le traitement du cancer de la vessie | |
| WO2014140933A3 (fr) | Procédé de pronostic et de traitement de métastases cancéreuses | |
| WO2013006443A3 (fr) | Découverte d'une mutation somatique dans le gène myd88 du lymphome lymphoblasmocytaire | |
| EA201370063A1 (ru) | Фосфолипидом рака | |
| NZ621638A (en) | Dna methylation in colorectal and breast cancer diagnostic methods | |
| NZ709167A (en) | Compositions and methods for diagnosing thyroid tumors | |
| NZ599194A (en) | Methods to predict clinical outcome of cancer | |
| WO2010051314A3 (fr) | Classification génomique de carcinomes pulmonaires non à petites cellules en fonction de profils d'altérations du nombre de copies de gènes | |
| PH12014502410A1 (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| MX2019000091A (es) | Metodo para el pronostico y tratamiento de cancer metastasico de los huesos originado de cancer de mama. | |
| HK1222888A1 (zh) | 预测在淋巴结阳性早期乳癌复发风险的方法 | |
| BR112015022977A2 (pt) | métodos para predição de risco de metástase em melanoma cutâneo | |
| WO2016066797A3 (fr) | Détermination de sous-groupes de pronostics du cancer de l'ovaire | |
| WO2019089858A3 (fr) | Procédés d'évaluation ou de surveillance d'une réponse à une thérapie cellulaire | |
| MX2017004816A (es) | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. | |
| RU2010149541A (ru) | Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением | |
| MX360225B (es) | Ensayos de receptores de esteroides para detectar celulas tumorales. | |
| Eapen | Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant? | |
| RU2012140862A (ru) | Способ прогнозирования риска возникновения переломов | |
| WO2011133500A3 (fr) | Détection et analyse des changements épigénétiques et génétiques dans le tissu tumoral | |
| HK1199097A1 (zh) | 用於癌症治疗的预测物 |